Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response. [electronic resource]
Producer: 20111003Description: 1051-7 p. digitalISSN:- 1523-6536
- Adult
- Aged
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Etoposide -- administration & dosage
- Female
- Graft vs Host Disease -- prevention & control
- Graft vs Tumor Effect
- HLA Antigens -- immunology
- Hematopoietic Stem Cell Transplantation -- methods
- Histocompatibility
- Humans
- Living Donors
- Lymphoma, Follicular -- drug therapy
- Male
- Methotrexate -- therapeutic use
- Middle Aged
- Remission Induction
- Rituximab
- Salvage Therapy
- Siblings
- Tacrolimus -- therapeutic use
- Transplantation Conditioning -- adverse effects
- Transplantation, Autologous
- Transplantation, Homologous
- Vidarabine -- administration & dosage
- Whole-Body Irradiation
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.